Steven H. Itzkowitz

Active 1985–2024

85
Papers
19,287
Citations
65
h-index
83
i10-index

Citations

Citations per year for Steven H. Itzkowitz1943: 2 citations1980: 1 citations1986: 4 citations1987: 3 citations1988: 5 citations1989: 11 citations1990: 10 citations1991: 12 citations1992: 11 citations1993: 18 citations1994: 37 citations1995: 20 citations1996: 44 citations1997: 25 citations1998: 26 citations1999: 27 citations2000: 30 citations2001: 58 citations2002: 31 citations2003: 25 citations2004: 53 citations2005: 83 citations2006: 92 citations2007: 82 citations2008: 153 citations2009: 134 citations2010: 180 citations2011: 189 citations2012: 155 citations2013: 193 citations2014: 208 citations2015: 237 citations2016: 211 citations2017: 206 citations2018: 180 citations2019: 570 citations2020: 545 citations2021: 508 citations2022: 416 citations2023: 345 citations2024: 591 citations2025: 323 citations2026: 14 citations1944–1979: no citations, so these years are not shown1981–1985: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,050 citing papers, 28.5% of this breakdownChina: 875 citing papers, 12.1% of this breakdownUnited Kingdom: 423 citing papers, 5.9% of this breakdownItaly: 336 citing papers, 4.7% of this breakdownGermany: 300 citing papers, 4.2% of this breakdownJapan: 282 citing papers, 3.9% of this breakdownCanada: 243 citing papers, 3.4% of this breakdownFrance: 239 citing papers, 3.3% of this breakdownNetherlands: 219 citing papers, 3% of this breakdownSpain: 193 citing papers, 2.7% of this breakdownAustralia: 170 citing papers, 2.4% of this breakdownSouth Korea: 125 citing papers, 1.7% of this breakdown
0%28.5%Other 24.2%

Fields

  • Biochemistry, Genetics and Molecular Biology45.3%
  • Medicine41%
  • Immunology and Microbiology6.6%
  • Nursing1.2%
  • Agricultural and Biological Sciences1.1%
  • Neuroscience0.8%
  • Other4%

Topics

  • Colorectal Cancer Screening and Detection6.6%
  • Inflammatory Bowel Disease6.3%
  • Gut microbiota and health4.6%
  • Genetic factors in colorectal cancer3.9%
  • Microscopic Colitis3.3%
  • Glycosylation and Glycoproteins Research2.8%
  • Other72.5%

Coauthors

All papers

Open in search
  1. Colorectal Cancer in Inflammatory Bowel Disease: Mechanisms and Management

    Authors: , - Gastroenterology 2021 cited by 794

  2. Multitarget Stool DNA Testing for Colorectal-Cancer Screening

    Authors: , , , , , , , - New England Journal of Medicine 2014 cited by 1,892

  3. Intestinal Inflammation and Cancer

    Authors: , - Gastroenterology 2011 cited by 1,110

  4. Cancers Complicating Inflammatory Bowel Disease

    Authors: , - New England Journal of Medicine 2015 cited by 663

  5. Mutant p53 Prolongs NF-κB Activation and Promotes Chronic Inflammation and Inflammation-Associated Colorectal Cancer

    Authors: , , , , , , , , , , , , , , , - Cancer Cell 2013 cited by 463

  6. Inflammation and Cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation

    Authors: , - American Journal of Physiology-Gastrointestinal and Liver Physiology 2004 cited by 1,269

  7. Histologic Inflammation Is a Risk Factor for Progression to Colorectal Neoplasia in Ulcerative Colitis: A Cohort Study

    Authors: , , , , , , , - Gastroenterology 2007 cited by 791

  8. Molecular mechanisms in colitis-associated colorectal cancer

    Authors: , , , - Oncogenesis 2023 cited by 89

  9. Gut microbiota density influences host physiology and is shaped by host and microbial factors

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Merjona Saliaj, Amy Nolan, Pamela Reyes-Mercedes, Carina A. Rodriguez, Sarah Aly, Kenneth Santa-Cruz, Lauren Peters, Mayte Suárez‐Fariñas, Ruiqi Huang, Ke Hao, Jun Zhu, Bin Zhang, Bojan Losic, Haritz Irizar, Won-Min Song, Antonio Di Narzo, Wenhui Wang, Benjamin L Cohen, Christopher J. DiMaio, David A. Greenwald, Steven H. Itzkowitz, Aimee L. Lucas, James F. Marion, Elana Maser, Ryan C. Ungaro, Steven Naymagon, Joshua Novak, Brijen J. Shah, Thomas Ullman, Peter Rubin, James George, Peter Legnani, Shannon Telesco, Joshua R. Friedman, Carrie Brodmerkel, Scott E. Plevy, Judy H. Cho, Jean‐Frédéric Colombel, Eric E. Schadt, Carmen Argmann, Marla C. Dubinsky, Andrew Kasarskis, Bruce E. Sands, Jeremiah J. Faith - eLife 2019 cited by 181

  10. Toll-Like Receptor-4 Promotes the Development of Colitis-Associated Colorectal Tumors

    Authors: , , , , , , , , , , , , , - Gastroenterology 2007 cited by 615

  11. Diversified Microbiota of Meconium Is Affected by Maternal Diabetes Status

    Authors: , , , , , , , , - PLoS ONE 2013 cited by 253

  12. A local tumor microenvironment acquired super-enhancer induces an oncogenic driver in colorectal carcinoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Communications 2022 cited by 45

  13. Pathology of mouse models of intestinal cancer: Consensus report and recommendations

    Authors: , , , , , , , , , , , , , , - Gastroenterology 2003 cited by 499

  14. The features of mucosa‐associated microbiota in primary sclerosing cholangitis

    Authors: , , , , , , , , , , , , , - Alimentary Pharmacology & Therapeutics 2016 cited by 153

  15. AGA Technical Review on the Diagnosis and Management of Colorectal Neoplasia in Inflammatory Bowel Disease

    Authors: , , , - Gastroenterology 2010 cited by 493

  16. Inflammatory Bowel Disease and Primary Sclerosing Cholangitis: A Review of the Phenotype and Associated Specific Features

    Authors: , , , , - Gut and Liver 2017 cited by 177

  17. Epidemiology of Gastric Malignancies 2000–2018 According to Histology: A Population-Based Analysis of Incidence and Temporal Trends

    Authors: , , , , , , , , , , - Clinical Gastroenterology and Hepatology 2023 cited by 43

  18. Contributions of Adenocarcinoma and Carcinoid Tumors to Early-Onset Colorectal Cancer Incidence Rates in the United States

    Authors: , , , , , , , , - Annals of Internal Medicine 2020 cited by 108

  19. Specificity of the Multi-Target Stool DNA Test for Colorectal Cancer Screening in Average-Risk 45–49 Year-Olds: A Cross-Sectional Study

    Authors: , , , , , , , - Cancer Prevention Research 2021 cited by 51

  20. Challenges and Possible Solutions to Colorectal Cancer Screening for the Underserved

    Authors: , , , , , , , , , , , , , , , - JNCI Journal of the National Cancer Institute 2014 cited by 220

  21. Diagnosis and management of dysplasia in patients with inflammatory bowel diseases

    Authors: , - Gastroenterology 2004 cited by 420

  22. GLUT1 glucose transporter expression in colorectal carcinoma

    Authors: , , , , , , , , - Cancer 1998 cited by 330

  23. An efficient strategy for evaluating new non-invasive screening tests for colorectal cancer: the guiding principles

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Finlay Macrae, Gerrit A. Meijer, Joshua Melson, Colm O’Morain, Susan Parry, Linda Rabeneck, David F. Ransohoff, Roque Sáenz, Hiroshi Saito, Silvia Sanduleanu‐Dascalescu, Robert E. Schoen, Kevin Selby, Harminder Singh, R. Steele, Joseph J.�Y. Sung, Erin L. Symonds, Sidney J. Winawer - Gut 2023 cited by 49

  24. Antigen-driven colonic inflammation is associated with development of dysplasia in primary sclerosing cholangitis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature Medicine 2023 cited by 41